Follow RSS for latest reports on this topicUlcerative Colitis - Market Research and Reports
Ulcerative colitis is a disease that affects around 120,000 people in the UK and causes inflammation of the large intestine - or colon. Symptoms vary in severity from pain and discomfort, through mucous in the stools to in the most severe cases blood in the stools. It is generally diagnosed by inspection of the colon by a hospital consultant - a colonoscopy.
The underlying cause of ulcerative colitis is still not known - though the disease is associated with dysfunction of the immune system. In the disease the body's own T-cells attack the lining of the bowel - and hence cause it to be inflamed. This bodies immune system then takes this inflammation to be a further sign of infection - increasing the immune response - in a vicious cycle. This situation is what people would term a flare-up.
Ulcerative colitis is treated using a variety of medications designed to either directly reduce the inflammation - such as steroids - or to reduce the immune response such a immunomodulators. Standard treatment for ulcerative colitis depends on extent of involvement and disease severity. The goal is to induce remission initially with medications, followed by the administration of maintenance medications to prevent a relapse of the disease. The concept of induction of remission and maintenance of remission is very important. The medications used to induce and maintain a remission somewhat overlap, but the treatments are different. Physicians first direct treatment to inducing a remission which involves relief of symptoms and mucosal healing of the lining of the colon and then longer term treatment to maintain the remission.The medications include; Asacol / Mesalazine / Colazine, Steroids, Azathioprine/immuno-modulators, Remicade and Laxatives.
Related Reports:
We found over 40 reports that matched your search.
Next 40 Matches >Refine your search, and find more matches, using the form above.
Ulcerative Colitis - Epidemiology Forecast to 2029
Ulcerative Colitis - Epidemiology Forecast to 2029SummaryUlcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation of the large intestine and the rectum. The inflammation occurs only in the innermost layer of the lining of the intestine. In UC, ulcers develop on the surface of the bowel lining; these may bleed and produce mucus. If the inflammation is con...Read More >>>
Published:
2020-10-19
Published by: Global Data
Prices Starting From:
$3396
Colitis - Pipeline Review, H2 2020
Colitis - Pipeline Review, H2 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Pipeline Review, H2 2020, provides an overview of the Colitis (Gastrointestinal) pipeline landscape.Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections, including those caused by a virus, p...Read More >>>
Published:
2020-07-31
Published by: Global Markets Direct
Prices Starting From:
$1700
Colitis Global Clinical Trials Review, H1, 2020
Colitis Global Clinical Trials Review, H1, 2020SummaryGlobalData's clinical trial report, “Colitis Global Clinical Trials Review, H1, 2020 provides an overview of Colitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Th...Read More >>>
Published:
2020-06-22
Published by: Global Data
Prices Starting From:
$2125
Inflammatory Bowel Disease (IBD) Treatment Market, By Type (Crohn’s Disease, and Ulcerative Colitis), By Route of Administration (Oral, and Injectable), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated
REPORT HIGHLIGHTInflammatory Bowel Disease (IBD) Treatment market was valued at USD 15.87 billion by 2019, growing with 4.1% CAGR during the forecast period, 2020-2026Market DynamicsA rise in the number of drugs available in clinical tests, growing prevalence of inflammatory bowel disease (IBD), and rising government initiatives related to the analysis of the causes and effective novel drug develo...Read More >>>
Published:
2020-06-01
Published by: AnalystView
Prices Starting From:
$2763
Ulcerative Colitis - Pipeline Review, H1 2020
Ulcerative Colitis - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H1 2020, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory B...Read More >>>
Published:
2020-04-30
Published by: Global Markets Direct
Prices Starting From:
$1700
Ulcerative Colitis - Pipeline Review, H2 2019
Ulcerative Colitis - Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H2 2019, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory B...Read More >>>
Published:
2019-12-16
Published by: Global Markets Direct
Prices Starting From:
$1700
Ulcerative Colitis Global Clinical Trials Review, H2, 2019
Ulcerative Colitis Global Clinical Trials Review, H2, 2019SummaryGlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2019 provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in ...Read More >>>
Published:
2019-12-04
Published by: Global Data
Prices Starting From:
$2125
Ulcerative Colitis (UC) - Market Review, Epidemiology And Market Forecast - 2029
FirstView Market Insight Ulcerative colitis -Market Review, Epidemiology and Market Forecast - 2029 provides in depth understanding of historical and forecasted epidemiology along with the detailed market insights. The report covers detailed information on the disease, treatment algorithm, existing treatment and upcoming treatment regimens, unmet needs, market drivers, market barriers, sales tr...Read More >>>
Published:
2019-11-26
Published by: First View Insight
Prices Starting From:
$2975
Ulcerative colitis- Pipeline Review, 2019
FirstView Market Insight Ulcerative Colitis- Pipeline Review, 2019 provides an overview of the pipeline landscape for Ulcerative Colitis- Pipeline Review, 2019. It provides comprehensive insights of all the clinical and non-clinical therapeutics in development with detailed description about the collaborations; deals; designations; patent information etc. These reports encourage the clients in d...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$1063
Ulcerative colitis-Pricing & Market Access and Landscape- 2019
Firstview Insight's Ulcerative colitis-Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Ulcerative colitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the cu...Read More >>>
Published:
2019-11-15
Published by: First View Insight
Prices Starting From:
$2125
Colitis - Pipeline Review, H2 2019
Colitis - Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Pipeline Review, H2 2019, provides an overview of the Colitis (Gastrointestinal) pipeline landscape.Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections, including those caused by a virus, p...Read More >>>
Published:
2019-09-23
Published by: Global Markets Direct
Prices Starting From:
$1700
Ulcerative Colitis Pipeline Drugs: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis H2 2020
GervanoRA’s Pipeline Drug Analytics Report Ulcerative Colitis Pipeline Drugs: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis H2 2020 provides a detailed overview on Ulcerative Colitis Competitive Space. Report provides deep insights on pipeline analytics outlook, drivers, restraints and unmet needs of Ulcerative Colitis pipeline drugs, Pipeline Analytics,...Read More >>>
Published:
2019-08-21
Published by: Gervano R A
Prices Starting From:
$1063
Colitis - Pipeline Drugs and Companies, Q2 2019
Summary Colitis pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into Colitis R&D activities including pipeline candidates, grants, developments, investments, technological advancements, and progress.Extensive Coverage of Pipeline CandidatesThe Colitis report covers all the pre-clinical compounds and clinical...Read More >>>
Published:
2019-04-08
Published by: VPA Research
Prices Starting From:
$1529
Ulcerative Colitis - Pipeline Review, H2 2018
Ulcerative Colitis - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H2 2018, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory B...Read More >>>
Published:
2018-10-31
Published by: Global Markets Direct
Prices Starting From:
$1700
Ulcerative Colitis Global Clinical Trials Review, H2, 2018
Ulcerative Colitis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2018 provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in ...Read More >>>
Published:
2018-09-28
Published by: Global Data
Prices Starting From:
$2125
Colitis - Pipeline Review, H2 2018
Colitis - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Pipeline Review, H2 2018, provides an overview of the Colitis (Gastrointestinal) pipeline landscape.Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections, including those caused by a virus, p...Read More >>>
Published:
2018-07-10
Published by: Global Markets Direct
Prices Starting From:
$1700
Ulcerative Colitis: Epidemiology Forecast to 2026
Ulcerative Colitis: Epidemiology Forecast to 2026SummaryUlcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by long-lasting inflammation and ulcers (sores) in the lining of the colon. UC commonly affects teenagers and young adults, and can result in poor development and growth; however, the disease can also occur in children and older individuals. Unlike Crohn’s disease ...Read More >>>
Published:
2018-06-26
Published by: Global Data
Prices Starting From:
$3396
Ulcerative Colitis: Global Drug Forecast and Market Analysis to 2026
Ulcerative Colitis: Global Drug Forecast and Market Analysis to 2026SummaryInflammatory bowel disease (IBD) refers to two chronic autoimmune diseases that cause intestinal inflammation: Crohn's disease (CD) and ulcerative colitis (UC). In UC, chronic inflammation affects the colon or large intestines, which are synonymous terms. UC usually manifests initially in the terminal part of the colon, the...Read More >>>
Published:
2018-06-26
Published by: Global Data
Prices Starting From:
$9346
Ulcerative Colitis - Pipeline Review, H1 2018
Ulcerative Colitis - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H1 2018, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory B...Read More >>>
Published:
2018-04-17
Published by: Global Markets Direct
Prices Starting From:
$1700
Global Ulcerative Colitis Partnering 2012-2018
Global Ulcerative Colitis Partnering Terms and Agreements since 2012 report provides the reader with the following key benefits:
• In-depth understanding of deal trends since 2012
• Access to headline, upfront, milestone and royalty data
• Comprehensive access to multiple deals entered into by the world’s biopharma companies since 2012
• Insight into key deal terms includedRead More >>>
Published:
2018-03-01
Published by: Current Partnering
Prices Starting From:
$1271
Ulcerative Colitis (UC) -Epidemiology Forecast to 2027
DelveInsight's Ulcerative Colitis (UC) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Ulcerative Colitis (UC) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• Japan Study Period: 2016-2027 Ulcerative...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$2763
Ulcerative Colitis (UC) - Market Insight, Epidemiology and Market Forecast - 2027
DelveInsight's Ulcerative Colitis (UC) - Market Insight, Epidemiology and Market Forecast - 2027 report provides a detailed analysis of the Ulcerative Colitis (UC) epidemiology and market outlook for the 7MM.Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• JapanStudy Period: 2016-2027Ulcerative Colitis (UC) Understanding and Treatment Algorith...Read More >>>
Published:
2018-02-14
Published by: Delve Insight
Prices Starting From:
$5313
Global Pentasa (Ulcerative Colitis) Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Pentasa (Ulcerative Colitis) Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Pentasa (Ulcerative Colitis) industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research a...Read More >>>
Published:
2017-12-18
Published by: S&P Consulting
Prices Starting From:
$2380
Ulcerative Colitis: Update Bulletin #1
This edition presents key opinion leader (KOL) views on recent developments in the ulcerative colitis (UC) market. Topics covered include: Takeda and Portal Instruments announcing the production of a needle-free formulation of Entyvio (vedolizumab); Qu Biologics reporting that QBECO achieved high clinical and endoscopic response ratesin a Phase II trial conducted in patients with moderate-to-sever...Read More >>>
Published:
2017-12-01
Published by: FirstWord Pharma
Prices Starting From:
$931
Global Ulcerative Colitis Partnering 2010-2017
Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides the reader with the following key benefits:
• In-depth understanding of deal trends since 2010
• Access to headline, upfront, milestone and royalty data
• Comprehensive access to multiple deals entered into by the world’s biopharma companies since 2010
• Insight into key deal terms includedRead More >>>
Published:
2017-11-01
Published by: Current Partnering
Prices Starting From:
$1271
Ulcerative Colitis - Pipeline Review, H2 2017
Ulcerative Colitis - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H2 2017, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory B...Read More >>>
Published:
2017-10-17
Published by: Global Markets Direct
Prices Starting From:
$1700
Ulcerative Colitis (UC) -Epidemiology Forecast to 2025
DelveInsight “Ulcerative Colitis (UC) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Ulcerative Colitis (UC) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Ulcerative Colitis (UC) prevalent or incident cases segmented by age, sex and subpopulations. The Report als...Read More >>>
Published:
2017-10-10
Published by: Delve Insight
Prices Starting From:
$2338
Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast – 2025
DelveInsight’s “Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period u...Read More >>>
Published:
2017-10-10
Published by: Delve Insight
Prices Starting From:
$4888
Ulcerative Colitis Market by Molecule Type (Biologics and Small Molecules), by Disease Type (Mild Ulcerative Colitis, Moderate Ulcerative Colitis, Severe Ulcerative Colitis), by Route of Administration (Oral and Injectables) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Ulcerative colitis (UC) is an inflammatory gastrointestinal disease that affects colon or large intestine. UC is characterized as an incurable disease with low mortality rate and is generally diagnosed in adolescence and early adulthood. As per NCBI, about 1.86 billion patients were diagnosed with UC globally in 2014, with 1.54 billion patients currently receiving treatment. Moreover, it is estima...Read More >>>
Published:
2017-09-01
Published by: Allied Market Research
Prices Starting From:
$2924
Ulcerative Colitis [2017]
Will oral therapies transform the treatment of ulcerative colitis?With Pfizer’s Xeljanz (tofacitinib) pending approval in the US, new oral therapies are set to transform the ulcerative colitis (UC) treatment landscape. While Pfizer’s JAK inhibitor clearly has a head-start, other companies have more selective JAK1-inhibitors in late-stage development, including AbbVie’s upadacitinib and Galap...Read More >>>
Published:
2017-09-01
Published by: FirstWord Pharma
Prices Starting From:
$6923
Colitis - Pipeline Review, H2 2017
Colitis - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Pipeline Review, H2 2017, provides an overview of the Colitis (Gastrointestinal) pipeline landscape.Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections, including those caused by a virus, p...Read More >>>
Published:
2017-07-11
Published by: Global Markets Direct
Prices Starting From:
$1700
Ulcerative Colitis [2016]: Bulletin #3
Gain new KOL insights on the latest events that have the potential to impact the treatment landscape of ulcerative colitis (UC). Topics covered include expert opinions on: Takeda announcing the presentation of real-world analyses for Entyvio (vedolizumab) in UC; InDex Pharmaceuticals announcing that it has enrolled the first patient in the Phase IIb CONDUCT trial for Kappaproct (cobitolimod); as w...Read More >>>
Published:
2017-07-01
Published by: FirstWord Pharma
Prices Starting From:
$888
Ulcerative Colitis - Pipeline Review, H1 2017
Ulcerative Colitis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H1 2017, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory B...Read More >>>
Published:
2017-05-09
Published by: Global Markets Direct
Prices Starting From:
$1700
Colitis - Pipeline Review, H1 2017
Colitis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Pipeline Review, H1 2017, provides an overview of the Colitis (Gastrointestinal) pipeline landscape.Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections, including those caused by a virus, p...Read More >>>
Published:
2017-02-28
Published by: Global Markets Direct
Prices Starting From:
$1700
Global Ulcerative Colitis Partnering 2010-2016
Provides understanding and access to the ulcerative colitis partnering deals and agreements entered into by the worlds leading healthcare companies.
Read More >>>Published:
2016-11-01
Published by: Current Partnering
Prices Starting From:
$1271
Ulcerative Colitis Global Clinical Trials Review, H2, 2016
Ulcerative Colitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2016 provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in ...Read More >>>
Published:
2016-09-28
Published by: Global Data
Prices Starting From:
$2125
Ulcerative Colitis: KOL Insight
Are UC biosimilars a real or perceived threat to branded drugs?Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; first-mover, Entyvio has a direct competitor coming on stream; and there is even talk of combination therapies and natural treatments in some quarters. What are the most influential key opini...Read More >>>
Published:
2016-09-01
Published by: FirstWord Pharma
Prices Starting From:
$6715
Colitis Global Clinical Trials Review, H1, 2016
Colitis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Colitis Global Clinical Trials Review, H1, 2016 provides an overview of Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Th...Read More >>>
Published:
2016-03-11
Published by: Global Data
Prices Starting From:
$2125
Ulcerative Colitis: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events happening in Ulcerative Colitis. Topics covered include opinions regarding Phase III data on Johnson & Johnson’s Stelara (ustekinumab) in Crohn’s disease and the launch of a new study looking at use of the therapy in patients with UC; the recent filing in the US and EU for Amgen’s ABP 501 (a proposed adalimumab biosimilar); the FDA advis...Read More >>>
Published:
2016-02-01
Published by: FirstWord Pharma
Prices Starting From:
$846
Ulcerative Colitis Forecast in 8 Major Markets 2016-2026
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ulcerative Colitis in 8 Major MarketsUlcerative Colitis (UC) is an inflammatory bowel disease (IBD) causing chronic inflammation in the colon, and is treated as an autoimmune disease. While sharing some features with Crohn's disease, UC is an intermittent disease with periods of symptoms interspersed with asymptomatic periods (g...Read More >>>
Published:
2016-02-01
Published by: Black Swan Analysis
Prices Starting From:
$5185
Additional Searches
You may also like to search separately for: Ulcerative Colitis